Search results
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 33 minutes agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 1 day agoOctober 2023, the FDA approved Cosentyx for treating moderate-to-severe hidradenitis suppurativa...
Is Sleeping on Your Stomach Bad for You? Experts Weigh in on Which Mattress Is Best
Prevention via Yahoo News· 2 days agoExperts say the best mattresses for stomach sleepers offer medium-firm support, cradle hips and...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 1 day agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 23 hours agoThese product candidates are being developed to treat patients with graft-versus-host disease, psoriatic arthritis, alpha-1-antitrypsin deficiency,...
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 12 hours agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
20 30-Minute Mediterranean Diet Dinners for Spring
Eating Well via Yahoo News· 2 days agoShe created this recipe for Lemongrass-&-Coconut Poached Salmon exclusively for EatingWell. It features a trifecta of inflammation-fighting...
VTYX DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Ventyx Biosciences, Inc. Investors to...
Digital Journal· 14 hours agoWHY: NEW YORK, NY - (NewMediaWire) - April 23, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant ...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 2 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
Johnson & Johnson (NYSE:JNJ) Releases FY 2024 Earnings Guidance
ETF DAILY NEWS· 5 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report) updated its FY 2024 earnings guidance on Tuesday. The company issued revenue guidance of $88.0 billion-$88.4 billion, compared to the consensus ...